Authors' Reply

J Am Soc Nephrol. 2020 Aug;31(8):1918-1919. doi: 10.1681/ASN.2020060799. Epub 2020 Jul 1.

Authors

Daniel Batlle¹, Maria Jose Soler², Paul A Welling³, Sundararaman Swaminathan⁴; COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group

Affiliations

¹ Nephrology Division, Feinberg School of Medicine, Northwestern University, Chicago, Illinois d-batlle@northwestern.edu.
² Nephrology Division, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
³ Nephrology Division, Johns Hopkins University, Baltimore, Maryland.
⁴ Nephrology Division, University of Virginia, Charlottesville, Virginia.

No abstract available

Keywords: ACE inhibitors; AKI; Angiotensin II receptor blockers; ace2; acute renal failure; covid-19; soluble ACE2.

Publication types

Letter
Comment

MeSH terms

Acute Kidney Injury*
Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Renin-Angiotensin System
SARS-CoV-2

Grants and funding